SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-24-000316
Filing Date
2024-02-15
Accepted
2024-02-15 20:06:25
Documents
3
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 9243
2 POWER OF ATTORNEY g084047_ex24.htm EX-24 8857
3 POWER OF ATTORNEY g084047_ex24a.htm EX-24 11840
  Complete submission text file 0001753926-24-000316.txt   31951
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005
Business Address
Friedberg Ezra M (Reporting) CIK: 0001679440 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41964 | Film No.: 24645510

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Issuer) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 106 COURT ROAD SUITE 202 BALTIMORE MD 21208
Business Address 106 COURT ROAD SUITE 202 BALTIMORE MD 21208 (212) 810-1377
Balmoral Financial Group LLC (Reporting) CIK: 0001988769 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41964 | Film No.: 24645509